Stratos Wealth Partners LTD. reduced its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 5.3% during the ...

In a report released today, Tejas Savant from Morgan Stanley maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price ...

Retirement Systems of Alabama cut its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 1.3% during the 4th ...

RBC Capital analyst Sean Dodge reiterated a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of $270.00. The ...

Clinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...

Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, ...

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

Shares of IQVIA Holdings Inc. IQV rallied 2.20% to $209.96 Thursday, on what proved to be an all-around mixed trading session ...

IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...

Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to ...

Clinical research company IQVIA (NYSE: IQV) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand, the company’s full-year ...